Recent developments in polymeric nanoparticle engineering and their applications in experimental and clinical oncology

S.M. Moghimi

Research output: Contribution to journalArticle

Abstract

Promising results have come from attempts to direct drugs, nucleic acids and diagnostic agents to tumours by using polymeric nanoparticles. Such carriers are versatile; their encapsulation capacity, drug release profile, and biological performance vary with their chemical makeup, morphology, and size. Polymeric nanoparticles may therefore be engineered for therapeutic and diagnostic purposes in accordance with the type, developmental stage and location of the cancer as well as the required route of administration. This article examines recent developments in design and engineering of polymeric nanoparticles and related platforms to include supramolecular systems such as nanocapsules and nanoparticle-based hydrogels, and assesses their potential diagnostic and therapeutic applications in experimental and clinical oncology.
Original languageEnglish
Pages (from-to)553-561
Number of pages9
JournalAnticancer agents in medicinal chemistry
Volume6
Issue number6
Publication statusPublished - Nov 2006

Fingerprint

Oncology
Nanoparticles
Nanocapsules
Hydrogels
Encapsulation
Pharmaceutical Preparations
Nucleic Acids
Tumors

Cite this

@article{2ddf749078364128850e242153d471a0,
title = "Recent developments in polymeric nanoparticle engineering and their applications in experimental and clinical oncology",
abstract = "Promising results have come from attempts to direct drugs, nucleic acids and diagnostic agents to tumours by using polymeric nanoparticles. Such carriers are versatile; their encapsulation capacity, drug release profile, and biological performance vary with their chemical makeup, morphology, and size. Polymeric nanoparticles may therefore be engineered for therapeutic and diagnostic purposes in accordance with the type, developmental stage and location of the cancer as well as the required route of administration. This article examines recent developments in design and engineering of polymeric nanoparticles and related platforms to include supramolecular systems such as nanocapsules and nanoparticle-based hydrogels, and assesses their potential diagnostic and therapeutic applications in experimental and clinical oncology.",
author = "S.M. Moghimi",
year = "2006",
month = "11",
language = "English",
volume = "6",
pages = "553--561",
journal = "Anticancer agents in medicinal chemistry",
issn = "1871-5206",
number = "6",

}

Recent developments in polymeric nanoparticle engineering and their applications in experimental and clinical oncology. / Moghimi, S.M.

In: Anticancer agents in medicinal chemistry, Vol. 6, No. 6, 11.2006, p. 553-561.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Recent developments in polymeric nanoparticle engineering and their applications in experimental and clinical oncology

AU - Moghimi, S.M.

PY - 2006/11

Y1 - 2006/11

N2 - Promising results have come from attempts to direct drugs, nucleic acids and diagnostic agents to tumours by using polymeric nanoparticles. Such carriers are versatile; their encapsulation capacity, drug release profile, and biological performance vary with their chemical makeup, morphology, and size. Polymeric nanoparticles may therefore be engineered for therapeutic and diagnostic purposes in accordance with the type, developmental stage and location of the cancer as well as the required route of administration. This article examines recent developments in design and engineering of polymeric nanoparticles and related platforms to include supramolecular systems such as nanocapsules and nanoparticle-based hydrogels, and assesses their potential diagnostic and therapeutic applications in experimental and clinical oncology.

AB - Promising results have come from attempts to direct drugs, nucleic acids and diagnostic agents to tumours by using polymeric nanoparticles. Such carriers are versatile; their encapsulation capacity, drug release profile, and biological performance vary with their chemical makeup, morphology, and size. Polymeric nanoparticles may therefore be engineered for therapeutic and diagnostic purposes in accordance with the type, developmental stage and location of the cancer as well as the required route of administration. This article examines recent developments in design and engineering of polymeric nanoparticles and related platforms to include supramolecular systems such as nanocapsules and nanoparticle-based hydrogels, and assesses their potential diagnostic and therapeutic applications in experimental and clinical oncology.

M3 - Article

VL - 6

SP - 553

EP - 561

JO - Anticancer agents in medicinal chemistry

JF - Anticancer agents in medicinal chemistry

SN - 1871-5206

IS - 6

ER -